LANCL2

LANCL2

A gene on chromosome 7q31.1-q31.33 that encodes an abscisic acid (ABA)-binding, G protein-coupled receptor involved in activating the ABA-signalling pathway in granulocytes.
References in periodicals archive ?
BT-11 is a first-in-class, orally-active, gut-restricted small molecule investigational new drug that targets the Lanthionine Synthetase C-Like 2 (LANCL2) pathway that impacts the gastrointestinal tract.
BT-11 is a first-in-class, oral, gut-restricted small molecule therapeutic with a unique mechanism of action that targets a novel pathway called Lanthionine Synthetase C-Like 2 (LANCL2).
The study, Non-clinical Toxicology and Toxicokinetic Profile of an Oral Lanthionine Synthetase C-Like 2 (LANCL2) Agonist, BT-11, was authored by researchers at Landos.